Beckmann Marianne, Jacomella Vincenzo, Kohler Malcom, Lachat Mario, Salem Amr, Amann-Vesti Beatrice, Husmann Marc
Clinic for Angiology, University Hospital Zurich and University of Zurich, Zurich, Switzerland; Angiology Division, Department of Internal Medicine, Kantonsspital St. Gallen, St Gallen, Switzerland.
Clinic for Angiology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
PLoS One. 2015 Oct 9;10(10):e0139887. doi: 10.1371/journal.pone.0139887. eCollection 2015.
Central augmentation index (cAIx) is an indicator for vascular stiffness. Obstructive and aneurysmatic vascular disease can affect pulse wave propagation and reflection, causing changes in central aortic pressures.
To assess and compare cAIx in patients with peripheral arterial disease (PAD) and / or abdominal aortic aneurysm (AAA).
cAIx was assessed by radial applanation tonometry (Sphygmocor) in a total of 184 patients at a tertiary referral centre. Patients were grouped as having PAD only, AAA only, or both AAA and PAD. Differences in cAIx measurements between the three patient groups were tested by non-parametric tests and stepwise multivariate linear regression analysis to investigate associations with obstructive or aneurysmatic patterns of vascular disease.
In the study sample of 184 patients, 130 had PAD only, 20 had AAA only, and 34 patients had both AAA and PAD. Mean cAIx (%) was 30.5 ± 8.2 across all patients. It was significantly higher in females (35.2 ± 6.1, n = 55) than males (28.4 ± 8.2, n = 129), and significantly higher in patients over 80 years of age (34.4 ± 6.9, n = 22) than in those under 80 years (30.0 ± 8.2, n = 162). Intergroup comparison revealed a significant difference in cAIx between the three patient groups (AAA: 27.3 ± 9.5; PAD: 31.4 ± 7.8; AAA & PAD: 28.8 ± 8.5). cAIx was significantly lower in patients with AAA, higher in patients with both AAA and PAD, and highest in patients with PAD only (beta = 0.21, p = 0.006).
Non-invasive assessment of arterial stiffness in high-risk patients indicates that cAIx differs according to the pattern of vascular disease. Measurements revealed significantly higher cAIx values for patients with obstructive peripheral arterial disease than for patients with aneurysmatic disease.
中心动脉增强指数(cAIx)是血管僵硬度的一个指标。阻塞性和动脉瘤性血管疾病可影响脉搏波传播和反射,导致中心主动脉压力发生变化。
评估和比较外周动脉疾病(PAD)和/或腹主动脉瘤(AAA)患者的cAIx。
在一家三级转诊中心,采用桡动脉压平式眼压测量法(Sphygmocor)对总共184例患者进行cAIx评估。患者被分为仅患有PAD、仅患有AAA或同时患有AAA和PAD。通过非参数检验和逐步多元线性回归分析来检验三组患者cAIx测量值的差异,以研究与血管疾病阻塞性或动脉瘤性模式的相关性。
在184例患者的研究样本中,130例仅患有PAD,20例仅患有AAA,34例同时患有AAA和PAD。所有患者的平均cAIx(%)为30.5±8.2。女性(35.2±6.1,n = 55)的cAIx显著高于男性(28.4±8.2,n = 129),80岁以上患者(34.4±6.9,n = 22)的cAIx显著高于80岁以下患者(30.0±8.2,n = 162)。组间比较显示,三组患者的cAIx存在显著差异(AAA组:27.3±9.5;PAD组:31.4±7.8;AAA合并PAD组:28.8±8.5)。AAA患者的cAIx显著较低,AAA和PAD患者的cAIx较高,仅患有PAD的患者cAIx最高(β = 0.21,p = 0.006)。
对高危患者进行动脉僵硬度的无创评估表明,cAIx因血管疾病模式而异。测量结果显示,阻塞性外周动脉疾病患者的cAIx值显著高于动脉瘤性疾病患者。